Related references
Note: Only part of the references are listed.The Role of PTPN22 Risk Variant in the Development of Autoimmunity: Finding Common Ground between Mouse and Human
David J. Rawlings et al.
JOURNAL OF IMMUNOLOGY (2015)
The Role of CTLA-4 Exon-1 49 A/G Polymorphism and Soluble CTLA-4 Protein Level in Egyptian Patients with Behcet's Disease
Sahar M. Abdel Galil et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Meta-analysis reveals an association of PTPN22 C1858T with autoimmune diseases, which depends on the localization of the affected tissue
J. Zheng et al.
GENES AND IMMUNITY (2012)
Regulation of TCR signalling by tyrosine phosphatases: from immune homeostasis to autoimmunity
Stephanie M. Stanford et al.
IMMUNOLOGY (2012)
CTLA-4 polymorphisms and susceptibility to Behcet's disease: a meta-analysis
Young Ho Lee et al.
MOLECULAR BIOLOGY REPORTS (2012)
Lack of the Phosphatase PTPN22 Increases Adhesion of Murine Regulatory T Cells to Improve Their Immunosuppressive Function
Rebecca J. Brownlie et al.
SCIENCE SIGNALING (2012)
Genetic susceptibility to Behcet's disease: role of genes belonging to the MHC region
Matteo Piga et al.
RHEUMATOLOGY (2011)
No association of CTLA-4 polymorphisms with susceptibility to Behcet disease
L. Du et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2009)
CTLA-4+49A/G polymorphism is associated with Behcet's disease in a Tunisian population
I. Ben Dhifallah et al.
TISSUE ANTIGENS (2009)
CTLA4 gene polymorphisms and soluble CTLA4 protein in Behcet's disease
K. S. Park et al.
TISSUE ANTIGENS (2009)
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
David Moher et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Regulation of CD28 expression on CD8+ T cells by CTLA-4
Martina Berg et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2008)
PTPN22 gene polymorphism in Behcet's disease
N. Sahin et al.
TISSUE ANTIGENS (2007)
A suggestive association of Fuchs heterochromic cyclitis with cytotoxic T cell antigen 4 gene polymorphism
Bernd M. Spriewald et al.
OPHTHALMIC RESEARCH (2007)
Does our current understanding of the molecular basis of immune tolerance predict new therapies for autoimmune disease?
Ingo H. Tarner et al.
NATURE CLINICAL PRACTICE RHEUMATOLOGY (2006)
Genetic influence of PTPN22 R620W polymorphism in tuberculosis
Luis M. Gomez et al.
HUMAN IMMUNOLOGY (2005)
CTLA-4 gene 49A/G polymorphism in Turkish patients with Behcet's disease
N Sallakci et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2005)
Quantifying heterogeneity in a meta-analysis
JPT Higgins et al.
STATISTICS IN MEDICINE (2002)
Polymorphsims of CTLA-4 exon 1+49, CTLA-4 promoter-318 and Fas promoter-670 in spondyloarthropathies
YH Lee et al.
CLINICAL RHEUMATOLOGY (2001)
Tyrosinase family proteins are antigens specific to Vogt-Koyanagi-Harada disease
K Yamaki et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
